BMI View: Canada's epidemiological profile will continue to be attractive to manufacturers of medicines
for non-communicable diseases. Despite the relatively rapid uptake of innovative pharmaceuticals, the
burden of chronic conditions will increase over the next 15 years. Like ..."
BMI View: The Canadian pharmaceutical and healthcare market will become increasingly attractive to
pharmaceutical companies over the next few years as economic growth in the country gradually
accelerates. The hospitable business environment, improving healthcare cover ..."
BMI View: The pharmaceutical manufacturing industry will continue to be an economic mainstay for
Puerto Rico. However, the country is gradually losing attractiveness as a global pharmaceutical production
hub, despite the diversification to the generic and biologic dru ..."
BMI View: Although Mexico has made great efforts to improve its regulatory framework and create a more
hospitable business environment to entice pharmaceutical companies, it is still hard for multinationals to
fully materialise their commercial benefit due to the sign ..."
BMI View: The Cuban government continues to seek greater foreign investment to help it achieve strong
economic growth, and is working hard to win the confidence of investors. Many companies in the
healthcare and pharmaceutical industries have embraced opportunities th ..."
BMI View: On the back of more promising a macroeconomic outlook in 2014, we believe the Canadian
pharmaceutical and healthcare market will be more attractive to pharmaceutical companies. Although
drugmakers will continue to face generic competition and drug pricing pr ..."
BMI View: The pharmaceutical manufacturing sector will remain an economic mainstay for Puerto Rico.
The local government is focused on defending the commonwealth nation's position as a global
pharmaceutical production hub by offering incentives for the expansion of ex ..."
BMI View: Pharmaceutical companies are facing far greater opportunities and challenges than
the Affordable Care Act (ACA). Healthcare reform in the US could have sought significant monetary
contributions from drugmakers, but this did not materialise in a meaningful se ..."
BMI View: We identified Mexico as 'the most promising emerging pharmaceutical market' in September
2013, Shortly after this, the approval of the energy reform bill reinforced our view that, over the long term,
healthier fiscal revenue will encourage the government to ..."
BMI View: The special economic zone allows Cuba to have greater openness in parts of its state without
the immediate danger of risking its deeply rooted communist system. Cuba has also taken other tacit
admissions of major structural changes to reform its economy and ..."